Stockscreener 앱 받기
1.14
11.76%
0.12
시간 외 거래:
1.13
-0.01
-0.88%
전일 마감가:
$1.02
열려 있는:
$1.03
하루 거래량:
230.75K
Relative Volume:
1.54
시가총액:
$62.59M
수익:
-
순이익/손실:
$-86.08M
주가수익비율:
-0.5284
EPS:
-2.1574
순현금흐름:
$-72.06M
1주 성능:
+19.99%
1개월 성능:
+15.83%
6개월 성능:
-0.87%
1년 성능:
-22.97%
1일 변동 폭
$1.01
$1.17
1주일 범위
$0.9035
$1.17
52주 변동 폭
$0.66
$1.79
Io Biotech Inc Stock (IOBT) Company Profile
명칭
Io Biotech Inc
전화
(457) 070-2980
주소
OLE MAALOES VEH 3, COPENHAGEN
IOBT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
1.14 | 62.59M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Io Biotech Inc 주식(IOBT)의 최신 뉴스
5 Best Stem Cell Companies to Invest In (May 2025) - Securities.io
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 - The Manila Times
IO Biotech's Co-Founder Mads Hald Andersen Highlights Advances in Cancer Vaccine Research at 2025 AACR Annual Meeting - Nasdaq
Breakthrough Cancer Vaccine Technology Reveals New Approach to Reprogram Tumor Environment - Stock Titan
IO Biotech unveils promising vaccine preclinical data By Investing.com - Investing.com Canada
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170 - The Manila Times
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting - The Manila Times
New Cancer Vaccine Data Shows Powerful Immune Response in Multiple Tumors | IOBT Stock News - Stock Titan
Short Sellers Gave Up on These 3 Names Recently - The Globe and Mail
4 Cheap Stocks With Solid Fundamentals to Offset Market Uncertainty - The Globe and Mail
Cotton Extending Strength to Friday Morning - The Globe and Mail
Healthcare Services (HCSG) Receives a Hold from William Blair - The Globe and Mail
3 Reasons AMTM is Risky and 1 Stock to Buy Instead - The Globe and Mail
Nano One 2025 Annual General Meeting of Shareholders - The Globe and Mail
Boeing doesn't expect the US trade war with China to slow its recovery - The Globe and Mail
[WATCH] Trading Gaps: Spot Big Moves Before They Happen - The Globe and Mail
Limbach (LMB): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail
Where Will Nvidia Stock Be in 5 Years? - The Globe and Mail
Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - The Globe and Mail
Viking Therapeutics Stock Pops But Struggles to Hold Gains - The Globe and Mail
CrowdStrike Stock is a Buy as Cyberthreat Environment Expands - The Globe and Mail
5 Top Psychedelic Stocks (2025) for Mental Health Investing - Securities.io
We're A Little Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn Rate - Yahoo Finance
Metastatic Melanoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail
Google (GOOGL) Offers U.S. Government Major Discounts as It Challenges Microsoft - The Globe and Mail
Seeking High Dividend Yield? Earn 9.6% from This Energy Stock Now. - The Globe and Mail
Tetra Tech Awarded £36 Million Multiple-Award Contract for Water Infrastructure Services - The Globe and Mail
NESR to Participate in Water Tower Research Fireside Chat on April 10 at 11am ET - The Globe and Mail
Financial Survey: Vistagen Therapeutics (NASDAQ:VTGN) versus IO Biotech (NASDAQ:IOBT) - Defense World
WSP Global Inc. (TSE:WSP) Receives C$284.85 Consensus Target Price from Brokerages - Defense World
Evergy, Inc. (NASDAQ:EVRG) Receives $69.08 Average Price Target from Brokerages - Defense World
Brokerages Set Aspen Aerogels, Inc. (NYSE:ASPN) PT at $19.11 - Defense World
Ag Futures Markets Are Suffering a Severe Case of Tariff Indigestion. When Will They Rebound? - The Globe and Mail
Prediction: This Artificial Intelligence (AI) Semiconductor Stock Could Start Soaring After April 16 - The Globe and Mail
Q1 Earnings Forecast for IO Biotech Issued By HC Wainwright - Defense World
Globus Medical acquires Nevro Corp. - Medical Buyer
NeuroOne Medical Technologies commences proposed underwritten RPO - Medical Buyer
Top 5 CRISPR Companies To Invest In (April 2025) - Securities.io
IO Biotech (NASDAQ:IOBT) Given “Buy” Rating at HC Wainwright - Defense World
Fresh Quarter, Fresh Momentum? Markets Eye April 2nd Tariff Announcement - The Globe and Mail
IO Biotech Inc. (IOBT) reports earnings - qz.com
New PM2 Gene Discovery by Aurora Cannabis Enhances Disease Resistance - Securities.io
IO Biotech secures over 400 million dkk in new capital - Dansk Industri
IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting - The Manila Times
IO Biotech Announces Acceptance Of Abstracts To Be Presented At The 2025 American Association For Cancer Research (AACR) Annual Meeting - MarketScreener
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Palantir Insiders including PLTR CEO Dump Shares as Valuation Skyrockets 340% - The Globe and Mail
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Globe and Mail
Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
TCEHY Earnings: Tencent Profits Leap on Gaming and Ads as Investors Wait on AI Returns - The Globe and Mail
IO Biotech Named Among Fast Company's World's Most Innovative Companies of 2025 - The Manila Times
Io Biotech Inc (IOBT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):